Page last updated: 2024-08-21

cyclopentane and Hypomelanosis

cyclopentane has been researched along with Hypomelanosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baek, KJ; Kim, DS; Kwon, SB; Lee, HK; Lee, S; Na, JI; Park, KC; Park, SH; Ryoo, IJ; Yoo, ID	1

Other Studies

1 other study(ies) available for cyclopentane and Hypomelanosis

Article	Year
The hypopigmentary action of KI-063 (a new tyrosinase inhibitor) combined with terrein. The Journal of pharmacy and pharmacology, 2008, Volume: 60, Issue:3 Topics: Agaricales; Animals; Caffeic Acids; Cell Line; Cell Survival; Cyclopentanes; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Enzyme Inhibitors; Hypopigmentation; Melanins; Melanocytes; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase	2008

Article

Year

The hypopigmentary action of KI-063 (a new tyrosinase inhibitor) combined with terrein.

The Journal of pharmacy and pharmacology, 2008, Volume: 60, Issue:3

Topics: Agaricales; Animals; Caffeic Acids; Cell Line; Cell Survival; Cyclopentanes; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Enzyme Inhibitors; Hypopigmentation; Melanins; Melanocytes; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase

2008